The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000018.4(ACADVL):c.1679-6G>A

CA312281

21019 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: 42f2d324-a5ae-4dcb-aa3e-b606dc669fe5
Approved on: 2022-12-14
Published on: 2022-12-14

HGVS expressions

NM_000018.4:c.1679-6G>A
NM_000018.4(ACADVL):c.1679-6G>A
NC_000017.11:g.7224636G>A
CM000679.2:g.7224636G>A
NC_000017.10:g.7127955G>A
CM000679.1:g.7127955G>A
NC_000017.9:g.7068679G>A
NG_007975.1:g.9803G>A
NG_008391.2:g.415C>T
NG_033038.1:g.14909C>T
ENST00000356839.10:c.1679-6G>A
ENST00000322910.9:c.*1634-6G>A
ENST00000350303.9:c.1613-6G>A
ENST00000356839.9:c.1679-6G>A
ENST00000542255.6:n.537-79G>A
ENST00000543245.6:c.1748-6G>A
ENST00000578033.1:n.4G>A
ENST00000578319.5:n.260-6G>A
ENST00000578711.1:n.1132G>A
ENST00000578809.5:n.251-6G>A
ENST00000579425.5:n.795-6G>A
ENST00000579546.1:n.414-6G>A
ENST00000582450.1:n.270G>A
ENST00000583074.5:n.300-79G>A
ENST00000583848.5:n.65-26G>A
ENST00000583850.5:n.450-6G>A
ENST00000583858.5:n.610-6G>A
ENST00000585203.6:n.870-6G>A
NM_000018.3:c.1679-6G>A
NM_001033859.2:c.1613-6G>A
NM_001270447.1:c.1748-6G>A
NM_001270448.1:c.1451-6G>A
NM_001033859.3:c.1613-6G>A
NM_001270447.2:c.1748-6G>A
NM_001270448.2:c.1451-6G>A
More

Likely Pathogenic

Met criteria codes 4
PM2_Supporting PP4_Moderate PS3_Supporting PM3_Strong
Not Met criteria codes 1
PP3

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The c.1679-6G>A variant in ACADVL is an intronic variant which creates a novel acceptor site in intron 17, experimentally shown to cause insertion of four nucleotides and causes a frameshift (PS3_Supporting; PMID: 9709714). This variant has been reported in several individuals affected with very long chain acyl CoA dehydrogenase (VLCAD) deficiency confirmed in trans to at least one pathogenic variant, presumed in trans to distinct ACADVL variants, and in the homozygous state in at least two individuals (PM3_Strong; PMIDs:23480858, 9709714, 8845838). Fibroblasts derived from one of these individuals showed no detectable VLCAD activity, which is highly specific for VLCAD deficiency (PP4_Moderate; PMID: 234808). The highest population minor allele frequency in gnomAD v2.1.1 is 0.0002264 in the Latino/Admixed American population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive VLCAD deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PS3_Supporting, PM3_Strong, PM2_Supporting, PP4_Moderate (ACADVL VCEP specifications version 1; approved November 8, 2021).
Met criteria codes
PM2_Supporting
The highest population minor allele frequency in gnomAD v2.1.1 is 0.0002264 in the Latino/Admixed American population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting).
PP4_Moderate
No detectable VLCAD activity in fibroblasts from this patient 11 in PMID 234808, plasma acylcarnitine profile consistent with VLCAD
PS3_Supporting
Creation of a novel acceptor, insertion of four nucleotides, causing a frameshift.

PM3_Strong
Described in the homozygous state in two individuals and confirmed in trans by cloning to F458L (now in review by VCEP)
Not Met criteria codes
PP3
SpliceAI gives a score of 0.99 for creation of a novel acceptor; however, not counted due to "double dipping" of this and PS3_Supporting showing the novel acceptor is used and a frameshift is created.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.